Skip to main content

Table 2 Summary of studies included in the regions-of-interest group

From: Comparison of white matter integrity between autism spectrum disorder subjects and typically developing individuals: a meta-analysis of diffusion tensor imaging tractography studies

 

Demographic character

 

Methodological character

  

Study

 

ASD group

TD group

 

Value

ROI tract

 

N a

Males

Mean age (years)

IQb

N c

Males

Mean age (years)

IQb

Diagnostic tools

Medication / comorbidity

Tesla

B factor

Number of direction

NEX

TE/TR (ms)

Type of WBA

FA

MD

RD

AD

ADC

CC

UF

Cg

SLF

ILF

IFOF

Fo

AF

Whole brain voxel-wise analysis study

Alexander and colleagues [24]

43

43

16.2

107

34

34

16.4

113

DSM-IV/ICD-10/ADI-R/ADOS-G

Yes/Yes

3

1,000

12

4

84/7,000

ROI

â—‹

â—‹

â—‹

â—‹

×

â—‹

×

×

×

×

×

×

×

Ameis and colleagues [43]

19

16

12.4

98.5

16

8

12.3

101

DSM-IV/ADI-R/ADOS

No/No

3

1,250

12

5

80/4,100

ROI

â—‹

â—‹

×

×

×

â—‹

×

â—‹

â—‹

×

×

×

×

Beacher and colleagues [58]

28

15

32

NA

30

15

30

NA

DSM-IV

Yes/No

1.5

1,000

64

NA

95/8,000

ROI

â—‹

×

×

×

×

â—‹

×

×

×

×

×

×

×

Ben Bashat and colleagues [64]

17

NA

NA

NA

NA

NA

9.6

NA

DSM-IV/ADI-R/ADOS

NA/NA

1.5

6,000

6

4

128/1,800

ROI

â—‹

â—‹

×

×

×

â—‹

×

â—‹

â—‹

×

×

×

×

Brito and colleagues [32]

8

8

9.53

NA

8

8

9.57

NA

DSM-IV

Yes/No

1.5

100

12

3

90/3,100

 

â—‹

×

×

×

×

â—‹

×

×

×

×

×

×

×

Catani and colleagues [67]

15

15

31

109

16

16

35

120

ICD-10/ADI/ADOS

NA/No

1.5

1,300

64

NA

107/1,500

Tractography

â—‹

â—‹

×

×

×

â—‹

×

â—‹

×

â—‹

×

×

×

Cheon and colleagues [62]

17

17

11

112

17

17

10.2

114

DSM-IV/ ADI-R/ADOS

Yes/No

1.5

900

30

2

86/6500

ROI

â—‹

â—‹

×

×

×

×

×

×

×

×

×

×

×

Conturo and colleagues [74]

17

14

26.5

104

17

14

26.1

105

ADI-R/ADOS

Yes/No

1.5

NA

7

10

94/1,51750

Tractography

â—‹

â—‹

â—‹

â—‹

×

â—‹

â—‹

×

×

â—‹

×

×

×

Fletcher and colleagues [59]

10

10

14.3

106

10

10

13.4

108

DSM-IV/ICD-10/ADI-R/ADOS

NA/NA

3

1,000

12

4

84/700

ROI

×

×

×

×

×

×

×

×

×

×

×

×

×

Hong and colleagues [60]

18

18

8.69

105

16

16

9.81

106

DSM-IV/ADI-R

No/No

1.5

1,000

15

2

104.4/8,000

ROI

â—‹

×

×

×

â—‹

â—‹

×

×

×

×

×

×

×

Ingalhalikar and colleagues [69]

45

42

10.5

NA

30

14

10.3

NA

NA

NA/NA

3

1,000

15

NA

70/16,900

ROI

â—‹

×

×

×

×

×

×

×

â—‹

×

×

×

×

Knaus and colleagues [66]

14

14

16.1

103

20

20

14.1

116

DSM-IV/ADI-ADOS

NA/No

3

1,000

15

NA

N/A

Tractography

â—‹

×

×

×

×

×

×

×

×

×

×

×

â—‹

Kumar and colleagues [26]

32

29

5

NA

16

12

5.5

Na

DSM-IV

NA/No

3

1,000

6

6

79/10,000

Tractography

â—‹

×

×

×

â—‹

â—‹

â—‹

â—‹

×

×

â—‹

×

â—‹

Langen and colleagues [73]

21

21

25.6

107

22

22

28.5

110

ICD-10/ADI-R/ADOS

No/No

3

1,300

32

NA

107/10,000

Tractography

â—‹

â—‹

â—‹

â—‹

×

×

×

×

×

×

×

×

×

Leemans and Jones [78]

43

43

16.2

108

34

34

16.4

113

DSM-IV/ICD-10/ADI-R/ADOS-G

NA/No

3

1,000

12

3

84/7,000

ROI

â—‹

â—‹

â—‹

â—‹

×

×

×

×

×

×

×

×

×

Lo and colleagues [25]

15

15

15.2

108

15

NA

15

111

DSM-IV/ICD-10/ADI-R

NA/No

3

6,000/4,000

102

NA

142/9,100, 130/9,600

ROI

â—‹

×

×

×

×

â—‹

â—‹

â—‹

×

×

×

×

â—‹

Poustka and colleagues [63]

18

16

19.7

111

18

16

9.7

113

ICD-10/ADI/ADOS

NA/No

1.5

1,000

6

15

78/4,700

ROI

â—‹

×

×

×

×

â—‹

â—‹

×

â—‹

×

×

â—‹

×

Pugliese and colleagues [57]

24

24

23.3

105

24

24

25.3

121

ICD-10/ADI-R

No/No

NA

1,300

32

NA

107/15,000

Tractography

â—‹

â—‹

×

×

×

×

â—‹

â—‹

×

â—‹

â—‹

â—‹

×

Sahyoun and colleagues [71]

9

7

12.8

101

12

9

13.3

106

ADIM-IV/ADI-R

No/No

3

700

60

Na

84/7,980

ROI

â—‹

×

×

×

×

×

×

×

×

×

×

×

×

Shukla and colleagues [65]

24

24

5

NA

16

12

5.9

NA

ADI-R/ADOS

Yes/No

3

200

15

4

99.4/1,0000

ROI

 

â—‹

â—‹

â—‹

×

â—‹

×

×

×

×

×

×

×

Sivaswamy and colleagues [68]

27

24

5

NA

16

12

5.9

NA

DSM-IV

Yes/No

3

1,000

6

6

160/11000

ROI

â—‹

×

×

×

×

×

×

×

×

×

×

×

×

Sundaram and colleagues [72]

50

43

4.79

NA

16

11

6.84

NA

DSM-IV0

Yes/No

3

1,000

6

6

79/10,000

Tractography

â—‹

×

×

×

â—‹

×

×

×

×

×

×

×

×

Thomas and colleagues [28]

12

12

28.5

107

18

18

22.4

112

DSM-IV/ ADI-R/ADOS

NA/No

3

850

6

12

82/4,900

ROI

â—‹

×

×

×

×

×

â—‹

×

×

â—‹

â—‹

×

×

Verhoeven and colleagues [61]

19

16

13.8

NA

33

24

12.9

NA

DSM-IV

Yes/No

3

800

45

2

55/11,043

Tractography

â—‹

×

×

×

â—‹

×

×

×

â—‹

×

×

×

×

Weinstein and colleagues [27]

22

NA

3.2

NA

28

NA

3.6

NA

DSM-IV ADI-R/ADOS

NA/Yes

1.5

1,000

15

2

94/11,043

Tractography

â—‹

â—‹

â—‹

â—‹

×

â—‹

×

â—‹

â—‹

×

×

×

×

  1. aNumber of ASD participants. bMean IQ of participants. cNumber of controls. AD axial diffusivity, ADC apparent diffusion coefficient, ADIR Autism Diagnostic Interview-Revised, ADOS Autism Diagnostic Observation Schedule, AF arcuate fasciculus, ASD autism spectrum disorder, CC corpus callosum, Cg cingulum, DSM-IV Diagnostic and Statistical Manual of Mental Disorders-IV, FA fractional anisotropy, Fo fornix, ICD-10 International Statistical Classification of Diseases and Related Health Problems-10, IFOF inferior frontal occipital fasciculus, ILF inferior longitudinal fasciculus, MD mean diffusivity, NA not available, NEX number of excitation, RD radial diffusivity, ROI region of interest, SLF superior longitudinal fasciculus, TD typically developing, TE echo time, TR repetition time, UF uncinate fasculus.